Melvin Rothberg
Vorstandsvorsitzender bei Rothberg Associates, Inc.
Profil
Melvin Rothberg is a Director of Viragen International, Inc. He joined Viragen in April 1998.
In April 1999, Mr. Rothberg assumed the position of an Executive Vice President.
Prior to joining Viragen, Mr. Rothberg served as a Vice President of Althin Medical, Inc. from 1990 to 1998.
He was a Director of Lotus Pharmaceuticals, Inc. Mr. Rothberg served as a Director and Manager of C.D.
Medical from 1983 to 1990.
Aktive Positionen von Melvin Rothberg
| Unternehmen | Position | Beginn |
|---|---|---|
| South Florida Bioscience Consortium | Vorsitzender | - |
Dharma Biomedical
 Dharma Biomedical BiotechnologyHealth Technology Dharma Biomedical is an American company that focuses on researching and developing biological products. The CEO of the private company is Melvin Rothberg. | Vorstandsvorsitzender | - |
| Rothberg Associates, Inc. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Melvin Rothberg
| Unternehmen | Position | Ende |
|---|---|---|
| LOTUS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 21.04.2008 |
| S.E. Asia Trading Co., Inc. | Direktor/Vorstandsmitglied | 14.12.2006 |
Viragen, Inc.
 Viragen, Inc. BiotechnologyHealth Technology Viragen, Inc. is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. The firm is located in Plantation, FL. | Corporate Officer/Principal | 22.04.2005 |
Viragen International, Inc.
 Viragen International, Inc. BiotechnologyHealth Technology The Group's principal activities are to research, develop, manufacture and market a natural human alpha interferon product indicated for treatment of a broad range of viral and malignant diseases. The Group produces a natural human alpha interferon product under the tradename of MultiferonTMfrom human white blood cells, also known as leukocytes. Natural interferon-alpha is one of the body's most important natural defense mechanisms to foreign substances like viruses, but it also stimulates and modulates the human immune system. In addition, interferon inhibits the growth of various viruses including those associated with diseases like hepatitis, some types of cancer, multiple sclerosis, and severe acute respiratory syndrome (SARS). | Direktor/Vorstandsmitglied | - |
| Cordis Dow BV | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LOTUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Viragen, Inc.
Viragen, Inc. BiotechnologyHealth Technology Viragen, Inc. is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. The firm is located in Plantation, FL. | Health Technology |
Viragen International, Inc.
Viragen International, Inc. BiotechnologyHealth Technology The Group's principal activities are to research, develop, manufacture and market a natural human alpha interferon product indicated for treatment of a broad range of viral and malignant diseases. The Group produces a natural human alpha interferon product under the tradename of MultiferonTMfrom human white blood cells, also known as leukocytes. Natural interferon-alpha is one of the body's most important natural defense mechanisms to foreign substances like viruses, but it also stimulates and modulates the human immune system. In addition, interferon inhibits the growth of various viruses including those associated with diseases like hepatitis, some types of cancer, multiple sclerosis, and severe acute respiratory syndrome (SARS). | Health Technology |
| S.E. Asia Trading Co., Inc. | Transportation |
| Althin Medical AB | Health Technology |
Advanced Processing & Imaging, Inc.
 Advanced Processing & Imaging, Inc. Packaged SoftwareTechnology Services Advanced Processing & Imaging, Inc. develops document management and workflow software solutions. Its products include OptiView document management, mPower business process automation, and OptiSpool iSeries report capture. The firm serves the education, government, healthcare, commercial, and small-to-medium size enterprises. Advanced Processing & Imaging was founded by Leonard Ferro, Juan Rodriguez, Lonnie Sanders, and Bob Sarneli in 1996 and is headquartered in Boca Raton, FL. | Technology Services |
ViraNative AB
 ViraNative AB Pharmaceuticals: MajorHealth Technology ViraNative AB develops pharmaceuticals and drugs. The company is based in Umeå, Sweden. ViraNative was acquired by Swedish Orphan International Holding AB on November 05, 2007. | Health Technology |
| South Florida Bioscience Consortium | |
Dharma Biomedical
Dharma Biomedical BiotechnologyHealth Technology Dharma Biomedical is an American company that focuses on researching and developing biological products. The CEO of the private company is Melvin Rothberg. | Health Technology |
| Rothberg Associates, Inc. | |
| Cordis Dow BV |
